✦ LIBER ✦

Response, relapse, re-treatment and viraemia in patients with chronic hepatitis C treated with alpha 2b interferon. A phase III study

✍ Scribed by Varagona, G.; Brown, D.; Kibler, H.; Scheuer, P.J.; Ashrafzadeh, P.; Sherlock, S.; McIntyre, N.; Dusheiko, G.

Book ID: 122218850
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 70 KB
Volume: 13
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(91)91297-T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with Interferon-Alpha2a Alone

Treatment with Interferon-Alpha2a Alone or Interferon-Alpha2a plus Ribavirin in Patients with Chronic Hepatitis C Previously Treated with Interferon-Alpha2a

✍ H. Bell, K. Hellum, S. Harthug, B., 📂 Article 📅 1999 🏛 Informa plc 🌐 English ⚖ 80 KB

Pharmacokinetics and enhanced PKR respon

Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin

✍ Y. Asahina; N. Izumi; N. Umeda; T. Hosokawa; K. Ueda; F. Doi; K. Tsuchiya; H. Na 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Predictors of sustained response, relaps

Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-α

✍ L. Chemello; L. Cavalletto; F. Noventa; P. Bonetti; C. Casarin; E. Bernardinello 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Combination therapy with interferon alph

Combination therapy with interferon alpha-2b and ribavirin in naive patients with chronic hepatitis C

✍ J. Juszczyk; B. Bolewska; J. Cianciara; J. Jablonska; P. Zaborowski; D. Niedzial 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Histological outcome in interferon alpha

Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis

✍ Robert Schvarcz; Hans Glaumann; Ola Weiland; Gunnar Norkrans; Rune Wejstål; Aril 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 916 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of